Search for: "Metabolite Laboratories, Inc."
Results 61 - 80
of 100
Sort by Relevance
|
Sort by Date
20 Jun 2011, 12:23 pm
Prometheus Laboratories, Inc. v. [read post]
20 Jun 2011, 7:28 am
Prometheus Laboratories, Inc. [read post]
7 Jun 2011, 12:42 pm
Metabolite Laboratories, Inc., 548 U. [read post]
3 Jun 2011, 9:49 am
Metabolite Laboratories, Inc., 548 U.S. 124, 135 (2006), because petitioner there had not adequately preserved the question.The question presented is: Whether 35 U.S.C. [read post]
15 Feb 2011, 9:55 am
Trigen Laboratories, Inc., 2011 WL 446148 (N.D. [read post]
8 Feb 2011, 1:29 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
6 Jan 2011, 8:52 am
In its first review of the district court decision in 2009 (Prometheus Laboratories, Inc. v. [read post]
29 Dec 2010, 2:57 am
Highlights this week included: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
22 Dec 2010, 4:30 am
By Jason RantanenPrometheus Laboratories, Inc. v. [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
20 Dec 2010, 11:48 am
Last Friday, in Prometheus Laboratories, Inc. v. [read post]
20 Dec 2010, 11:48 am
Last Friday, in Prometheus Laboratories, Inc. v. [read post]
20 Dec 2010, 10:31 am
Prometheus Laboratories, Inc. v. [read post]
17 Dec 2010, 11:06 am
Metabolite Laboratories, Inc., 548 U.S. 124, 138-39 (2006), concluding that the claims do not cover a process for transforming a bodily sample, but rather merely instruct the user to obtain test results and think about them. [read post]
15 Dec 2010, 7:36 am
Both of those cases (Classen Immunotherapies, Inc. v. [read post]
13 Dec 2010, 2:00 am
The Federal Circuit will have an opportunity to provide additional guidance in two pending cases: Prometheus Laboratories, Inc. v. [read post]
13 Dec 2010, 2:00 am
The Federal Circuit will have an opportunity to provide additional guidance in two pending cases: Prometheus Laboratories, Inc. v. [read post]
1 Dec 2010, 9:59 pm
Metabolite Labs., Inc. [read post]
12 Oct 2010, 8:56 pm
General Media goof up over India-EU ‘settlement’ (Spicy IP) (Spicy IP) (Generic Pharmaceuticals and IP) Burdened with brackets, biodiversity ABS protocol needs political will to survive (IP Watch) Brazil: Deposit of microorganism for patents applications (IP tango) India: Student groups ask for reconsideration of TRIPS-plus provisions of EU-India FTA (Spicy IP) India: DIPP receives diverse replies to its compulsory licensing policy discussion paper (Spicy IP) India: An earnest call for… [read post]
29 Sep 2010, 12:49 pm
Signature Financial Group, Inc. [read post]
